GW amends planned NASDAQ listing

GW Pharmaceuticals plc (LSE:GWP) said it now plans to sell up to 3.5 million ADSs in a public offering on NASDAQ. Each ADS represents 12 common shares. Last month, GW proposed to raise up to $50 million in the offering. Lazard; Cowen; Canaccord; and Roth Capital Partners are underwriters. ...